Author

Ty A. Schroeder

University of Minnesota

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Ashma ChakrawartiiD· 2 shared Christopher M. BastingiD· 2 shared Erik Swanson· 2 shared Nichole R. KlattiD· 2 shared Robert LangatiD· 2 shared Robin R. Shields‐CutleriD· 2 shared Ross T. CromartyiD· 2 shared Adrian Velez· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ashma ChakrawartiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gut barrier integrity biomarkers are associated with increased inflammation and predict disease status in hospitalized COVID-19 patients

Christopher M. Basting, Ty A. Schroeder, Kathie G. Ferbas, Robin R. Shields‐Cutler, Nicole H. Tobin, Ashma Chakrawarti, Adrian Velez, Erik Swanson, Courtney Ann Broedlow, Robert Langat, Ross T. Cromarty, Luca Schifanella, Carolyn T. Bramante, Grace M. Aldrovandi, Anne W. Rimoin, , Nichole R. Klatt

This study identifies gut barrier integrity biomarkers linked to inflammation and disease severity in hospitalized COVID-19 patients using plasma biomarker analysis and a random forest model.

Scientific Reports · Jul 3, 2026Peer-reviewedImmunology

Pre-treatment Microbiome Diversity and Function is associated with Expansion of Cytotoxic and Regulatory Immune Populations after N-803 treatment in People with HIV

Ashma Chakrawarti, Ross T. Cromarty, Christopher M. Basting, Jodi L. Anderson, Ty A. Schroeder, Kevin Escandón-Vargas, Robin R. Shields‐Cutler, Robert Langat, Erik Swanson, Patrick Soon‐Shiong, Jeffrey T. Safrit, Leonard S. Sender, Sandeep K. Reddy, Jeffrey S. Miller, Joshua Rhein, , Nichole R. Klatt

This study shows that pre-treatment gut microbiome diversity in HIV patients correlates with immune activation and reduced HIV RNA+ cells after N-803 treatment.

bioRxiv · Oct 1, 2025 · PreprintMicrobiology